RT_Focus: Focus Group Interview Study on Patient Experiences and Satisfaction

Sponsor
Universitair Ziekenhuis Brussel (Other)
Overall Status
Recruiting
CT.gov ID
NCT04625842
Collaborator
(none)
96
1
2
15
6.4

Study Details

Study Description

Brief Summary

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members.

Condition or Disease Intervention/Treatment Phase
  • Other: Focus group interview
N/A

Detailed Description

In order to improve quality of care at the department, the investigators will perform a focus group interview study with patients and family members. They will perform 6 (3 in the French, and 3 in the Dutch language) focus group interviews with patients and 6 (3 in the French, and 3 in the Dutch language) with family members. Following research questions will be answered:

  • What elements of care (ie infrastructure, interpersonal contact, information, communication) are good to the opinion of patients and family members?

  • What elements of care can be improved?

  • What are priorities in improvement of the care for patients and families?

  • What actions could possibly be taken in order to improve the care for future patients?

Because the radiotherapy ward exists of 3 clusters, one per type of treatment conducted, the investigators will perform 6 focus group interviews with patients (3 in the French, and 3 in the Dutch language) and 6 focus group interviews with family members (3 in the French, and 3 in the Dutch language).

Investigators will collect sex, main diagnosis (of patients), age and nationality of all participants at the beginning of each focus group interview. They will transcribe all interviews verbatim and analyze them in Nvivo software as provided by the VUB. Participant characteristics will be analyzed by descriptive statistics.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
96 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Focus group interview studyFocus group interview study
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Quality Improvement Actions on the Radiotherapy Ward: Focus Group Interview Study on Patient Experiences and Satisfaction
Actual Study Start Date :
Sep 1, 2020
Anticipated Primary Completion Date :
Sep 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patient focus group

Patients who received radiation treatment

Other: Focus group interview
Group interview with patients who received radiation treatment

Experimental: Family focus group

Family of patients who received radiation treatment

Other: Focus group interview
Group interview with patients who received radiation treatment

Outcome Measures

Primary Outcome Measures

  1. Quality of care [immediately after treatment]

    To identify elements of care that need improvement by using open ended interview questions and interaction between different participants

  2. Problem solving [immediately after treatment]

    To identify solutions for problems in care by using open ended interview questions and interaction between different participants

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion criteria for patients:
  • Patients (18+) who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel

  • Dutch and French speaking

  • Start date of treatment max 6 months before inclusion

  • Estimated sample size: 5-8 x 6 patients

Inclusion criteria for family members:
  • All family members (+18) of patients who were treated for cancer, receiving radiotherapy, and followed thereafter in the UZ Brussel

  • Dutch and French speaking

  • Start date of treatment of patient max 6 months before inclusion

  • Estimated sample size: 5-8 x 6 family members

Contacts and Locations

Locations

Site City State Country Postal Code
1 UZ Brussel Brussel Belgium 1090

Sponsors and Collaborators

  • Universitair Ziekenhuis Brussel

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mark De Ridder, Professor in oncology, Universitair Ziekenhuis Brussel
ClinicalTrials.gov Identifier:
NCT04625842
Other Study ID Numbers:
  • 2020-087
First Posted:
Nov 12, 2020
Last Update Posted:
Nov 12, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mark De Ridder, Professor in oncology, Universitair Ziekenhuis Brussel

Study Results

No Results Posted as of Nov 12, 2020